Biotech · Private company · Palo Alto, CA, US
Vecgen, Inc
Track this companyFree. Adds Vecgen, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Pre-Market Approval (PMA) Enabling Validation of a Diagnostic to Predict Immune Responses to AAV-based Therapies for GNE Myopathy and Broad Ranging IndicationsFiscal year 2026 · $333.7KNIH RePORTER 1R42AR087918-01 · fetched Nov 12, 2026